Tegan Taylor

speaker
2,688 appearances 36 recordings 1 series first heard Mar 2018 last heard 31 Jul

Tegan Taylor’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Jul OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment
Right.
And I think when you understand that framing, that reference framing, it actually can inspire a lot of confidence.
And I saw one of the co-inventors of the rotavirus vaccine, Paul Offit, was quoted in some American media this week saying, in the history of vaccines, side effects have always appeared within two months of administration.
There's never been a case where a couple of years down the track, they pick up something that wasn't picked up
initially, which I found really interesting because that is one of the big sticking points, I think, for a lot of people.
For sure.
And one last question, another COVID-related question from David, who's asking about influenza numbers and what the numbers this year and last year tell us about the effectiveness of vaccines versus restricting international travel, and is wondering whether once COVID vaccines roll out more broadly, whether we're going to have to choose a trade-off between managing COVID like we manage the flu, where there are deaths and lots and lots of cases each year, or not travelling internationally but keeping close to zero fatalities?
I thought that comment about how we wouldn't accept dirty water, but we accept dirty air was really, that was a real light bulb moment for me.
should.
Well, that's all from our mailbag today.
Of course, again, you can send your questions in at healthreport at abc.net.au.
See you then.
This is an ABC podcast. voice-verified
And me, Tegan Taylor. voice-verified
Also on diabetes, could a new class of drugs slash the number of people with diabetes who go on to need dialysis or kidney transplants? voice-verified
That's GP Dr. Sam Hurd, Medical Director of the Central Australian Aboriginal Congress, ending Sarah Seji's report. voice-verified
And staying with diabetes, renal dialysis costs tens of thousands of dollars a year per patient. voice-verified
And as we just heard, the condition it treats, end-stage kidney disease, is commonly caused by diabetes. voice-verified
Now a group of Australian researchers has modelled whether a new class of drugs could stave off end-stage kidney disease, saving lives as well as money. voice-verified
The drugs are called sodium glucose co-transporter 2 inhibitors, or SGLTI2Is for short, and they're a shift away from simply managing blood glucose, which is how diabetes is generally treated now. voice-verified
Showing 81–100 of 2,688 · page 5 of 135 ← Previous Next →